Ignite Creation Date:
2024-05-06 @ 3:25 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02289222
Status:
TERMINATED
Last Update Posted:
2019-11-05
First Post:
2014-10-17
Brief Title:
1454GCC Anti-PD-1 MK-3475 and IMiD Pomalidomide Combination Immunotherapy in RelapsedRefractory Multiple Myeloma
Sponsor:
Ashraf Badros
Organization:
University of Maryland Baltimore